Dynamique moléculaire de la transformation hématopoïétique (Dynamo)

Les 20 dernières publications

Titre Auteurs Date de publication Source
Diamond-Blackfan anemia, the archetype of ribosomopathy: How distinct is it from the other constitutional ribosomopathies? L. Da Costa, Jessica Platon 01/01/2024 Blood Cells, Molecules, and Diseases
Sensitivity, specificity, and accuracy of molecular profiling on circulating cell-free DNA in refractory or relapsed multiple myeloma patients, results of MM-EP1 study Cyril Quivoron, H. Lecourt, Vincent Ribrag 01/01/2024 Leukemia and Lymphoma
Immunosuppressant mycophenolate mofetil for patients with steroid-refractory immune-related hepatitis induced by checkpoint inhibitors in oncology Jean Marie Michot 01/11/2023 European Journal of Cancer
The Antioxidant TEMPOL Protects Human Hematopoietic Stem Cells From Culture-Mediated Loss of Functions Elia Henry, Vilma Barroca, Nathalie Dechamps, Francoise Pflumio, Marie Laure Arcangeli 01/10/2023 Stem cells translational medicine
FANCA deficiency promotes leukaemic progression by allowing the emergence of cells carrying oncogenic driver mutations Patrycja Pawlikowska, Alessia Oppezzo, Filippo Rosselli 08/09/2023 Oncogene
Exploring the genetic landscape of HCV-related B-cell lymphomas using whole exome sequencing Jean Marie Michot 01/06/2023 Leukemia
The NFIA-ETO2 fusion blocks erythroid maturation and induces pure erythroid leukemia in cooperation with mutant TP53 Alexandre Fagnan, Thomas Mercher 04/05/2023 Blood
Sequence analyses of relapsed or refractory diffuse large B-cell lymphomas unravel three genetic subgroups of patients and the GNA13 mutant as poor prognostic biomarker, results of LNH-EP1 study Jean Marie Michot, Clémentine Sarkozy, Olivier A. Bernard, Vincent Ribrag 01/04/2023 American Journal of Hematology
From normal hematopoiesis to malignancies: Highlights from the 2021 Meeting of the Club Hematopoiesis and Oncogenesis Adlen Foudi 01/03/2023 Bulletin du Cancer
High caspase 3 and vulnerability to dual BCL2 family inhibition define ETO2::GLIS2 pediatric leukemia Zakia Aid, Elie Robert, Cécile K. Lopez, Fabien Boudia, Melchior Le Mene, Julie Riviere, Marie Baille, Salima Benbarche, Alexandre Fagnan, Cécile Thirant, Laetitia Federici, Muriel Gaudry, Camille Lobry, Thomas Mercher 01/03/2023 Leukemia
Precision Medicine Approach Based on Molecular Alterations for Patients with Relapsed or Refractory Multiple Myeloma: Results from the MM-EP1 Study Cyril Quivoron, Olivier A. Bernard, Vincent Ribrag, Jean Marie Michot 01/03/2023 Cancers
Targeting M2 Macrophages with a Novel NADPH Oxidase Inhibitor Stéphanie Solier 01/02/2023 Antioxidants
Caspase Inhibition Modulates Monocyte-Derived Macrophage Polarization in Damaged Tissues Gérard Pierron 01/02/2023 International Journal of Molecular Sciences
Immune-related generalised oedema – A new category of adverse events with immune checkpoint inhibitors Jean Marie Michot 01/01/2023 European Journal of Cancer
GWAS meta-analysis of intrahepatic cholestasis of pregnancy implicates multiple hepatic genes and regulatory elements Remi Favier 01/12/2022 Nature Communications
HDAC1 and PRC2 mediate combinatorial control in SPI1/PU.1-dependent gene repression in murine erythroleukaemia Sebastian Gregoricchio, Michela Esposito, Laure Delestré, M’boyba Khadija Diop, Christel Guillouf 12/08/2022 Nucleic Acids Research
Cell-free DNA sequencing as a potential screening tool for phase I targeted treatment in refractory/relapse diffuse large B-cell lymphoma Cyril Quivoron, Vincent Ribrag, Clémentine Sarkozy 01/08/2022 Haematologica
Stepwise GATA1 and SMC3 mutations alter megakaryocyte differentiation in a Down syndrome leukemia model Brahim Arkoun, Stefania Mazzi, Mathieu Vieira, Imanci Aygun, Nathalie Droin, Najet Debili, Isabelle Plo, Hana Raslova, William Vainchenker 15/07/2022 Journal of Clinical Investigation
Screening of ETO2-GLIS2-induced Super Enhancers identifies targetable cooperative dependencies in acute megakaryoblastic leukemia Salima Benbarche, Cécile K. Lopez, Zakia Aid, Cécile Thirant, Marie Charlotte Laiguillon, Séverine Lecourt, Marion Antonini, Jiang Hu, Thomas Mercher, Camille Lobry 01/02/2022 Science advances
RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axis Eric Solary, Nathalie Droin 01/12/2021 Nature Communications

Nombre de publications du laboratoire par domaine scientifique (2016-2021)

Chaque publication du laboratoire peut être rangée dans une ou plusieurs disciplines scientifiques : la figure ci-dessus présente le nombre de publications du laboratoire pour chaque discipline de la classification ASJC (Elsevier)